Rivaroxaban als effektive Therapieoption der Livedovaskulopathie

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Abstract

The livedoid vasculopathy is a rare disease caused by thromboembolic occlusion of small and medium vessels in the superficial dermal plexus. Immunosuppressive treatment was often ineffective and resulted in a refractory disease cause. The efficiency of anticoagulants in the treatment of the disease was described a couple of years ago. Here, we report successful treatment with rivaroxaban and fast achievement of remission in a 30-year-old patient with livedoid vasculopathy.

Translated title of the contribution
Rivaroxaban as an Effective Treatment of Livedoid Vasculopathy

Details

Original languageGerman
Pages (from-to)199-201
Number of pages3
JournalAktuelle Dermatologie
Volume43
Issue number5
Publication statusPublished - 1 May 2017
Peer-reviewedYes

External IDs

ORCID /0000-0002-8217-6872/work/152545006
ORCID /0000-0002-2164-4644/work/152545843
ORCID /0000-0002-4330-1861/work/152544350

Keywords

ASJC Scopus subject areas